Initial serum sodium concentration determines the decrease in sodium level after terlipressin administration in patients with liver cirrhosis

SpringerPlus

Volumn 2, Issue 1, 2013, Pages 1-9

  Kang, Yeo Jin ^a   Bae, Eun Jin ^a   Hwang, Kyungo ^a   Jeon, Dae Hong ^a   Jang, Ha Nee ^a   Cho, Hyun Seop ^a   Chang, Se Ho ^a,b   Park, Dong Jun ^a,b  

^a Gyeongsang National University   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

Hyponatremia; Liver cirrhosis; Terlipressin

Indexed keywords

EID: 84887297798     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-2-519     Document Type: Article

References (23)

1. Ackermann D (2009) Treatment of Ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis. Ther Umsch 66:747-751.
2. Bosch JBA (1999) Clinical manifestations and management of bleeding episodes in cirrhotics, 2nd edn. Oxford Textbook of Clinical Hepatology, Oxford, pp 671-693.
3. Bosma JW, van Meyel JJ, Siegert CE (2010) Hepatorenal syndrome. Ned Tijdschr Geneeskd 154:A1355.
4. Bruha R, Marecek Z, Prochazka V, Lata J, Spicak J, Ehrmann J et al (2009) Doubleblind randomized multicenter study comparing the efficacy and safety of 10-day to 5-day terlipressin treatment of bleeding esophageal varices. Hepatogastroenterology 56:390-394.
5. Escorsell A, Ruiz del Arbol L, Planas R, Albillos A, Banares R, Cales R et al (2000) Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology 32:471-476.
6. Feu F, Ruiz del Arbol L, Banares R, Planas R, Bosch J (1996) Double-blind randomized controlled trial comparing terlipressin and Somatostatin for acute variceal hemorrhage. Variceal bleeding study group. Gastroenterology 111:1291-1299.
7. Forsling ML, Aziz LA, Miller M, Davies R, Donovan B (1980) Conversion of triglycylvasopressin to lysine-vasopressin in man. J Endocrinol 85:237-244.
8. Freeman JG, Cobden I, Record CO (1989) Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol 11:58-60.
9. Kim KALJ (1989) Terlipressin therapy for the hepatorenal syndrome: randomized, prospective, controlled trials. Korean J Gastroenterol 11:58-60.
10. Krag A, Bendtsen F, Pedersen EB, Holstein-Rathlou NH, Moller S (2008) Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects. Am J Physiol Renal Physiol 295:F1295-F1300.
11. Krag A, Hobolth L, Moller S, Bendtsen F (2010) Hyponatraemia during terlipressin therapy. Gut 59:417-418.
12. Krag A, Moller S, Bendtsen F (2011) Hyponatremia in patients treated with terlipressin: mechanisms and implications for clinical practice. Hepatology 53:368-369, author reply 369-70.
13. Lo GH, Chen WC, Wang HM, Lin CK, Chan HH, Tsai WL et al (2009) Low-dose terlipressin plus banding ligation versus low-dose terlipressin alone in the prevention of very early rebleeding of Oesophageal varices. Gut 58:1275-1280.
14. Nazar A, Pereira GH, Guevara M, Martin-Llahi M, Pepin MN, Marinelli M et al (2010) Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 51:219-226.
15. Oliver JA, Verna EC (2009) Afferent mechanisms of sodium retention in cirrhosis and hepatorenal syndrome. J Gastroenterol Hepatol 24:1707-1709.
16. Pliska V, Chard T, Rudinger J, Forsling ML (1976) In vivo activation of synthetic hormonogens of lysine vasopressin: Na-glycyl-glycyl-glycyl-[8-lysine] vassopressin in the cat. Acta Endocrinol (Copenh) 81:474-481.
17. Rahimi RS, Rockey DC (2013) End-stage liver disease complications. Curr Opin Gastroenterol 29:257-263.
18. Sanyal AJ, Bosch J, Blei A, Arroyo V (2008) Portal hypertension and its comclications. Gastroenterology 134:1715-1728.
19. Sass DA, Chopra KB (2009) Portal hypertension and variceal hemorrhage. Med Clin North Am 93:837-853.
20. Sola E, Lens S, Guevara M, Martin-Llahi M, Fagundes C, Pereira G et al (2010) Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension. Hepatology 52:1783-1790.
21. Testro AG, Angus PW (2009) Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome. J Gastroenterol Hepatol 24:1707-1709.
22. Toubia N, Sanyal AJ (2008) Portal hypertension and variceal hemorrhage. Med Clin North Am 92:551-574.
23. Walker S, Kreichgauer HP, Bode JC (1997) Terlipressin or Somatostatin for acute variceal hemorrhage. Gastroenterology 112:1777.